Sex differences in locomotor activity following β-endorphin in the ventrolateral periaqueductal gray

被引:11
|
作者
Krzanowska, E
Bodnar, RJ
机构
[1] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA
[2] CUNY Queens Coll, Neuropsychol Doctoral SubProgram, Flushing, NY 11367 USA
关键词
ambulatory activity; stereotypic activity; beta-endorphin; sex differences; ventrolateral periaqueductal gray;
D O I
10.1016/S0031-9384(99)00242-5
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Both morphine and selective opioid receptor agonists produce typical biphasic effects upon activity in male rats with initial reductions in activity followed by subsequent increases in activity. Sex differences have been observed in a number of opioid-mediated responses, including the observation that microinjection of the opioid peptide, beta-endorphin into the ventrolateral periaqueductal gray (vIPAG) produces more pronounced analgesia in male rats relative to female rats. The present study evaluated whether beta-endorphin (5.2-26 mu g) in the vIPAC produced biphasic activity effects in male and female rats. Both male and female rats displayed initial reductions in total, ambulatory, and stereotypic activity following beta-endorphin in the vIPAG. Whereas male rats displayed subsequent (90-120 min) increases in total and ambulatory activity following beta-endorphin in the vlpAG, female rats tested during the estrous stage of their estrous cycle failed to display any changes. These sex differences in the opioid modulation in the pattern of activity measures in the vIPAG are discussed in terms of the roles of sex hormones in opioid peptide processing within the vIPAG. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:595 / 598
页数:4
相关论文
共 50 条
  • [41] The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray
    Millington, William R.
    Yilmaz, M. Sertac
    Feleder, Carlos
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (06): : 612 - 615
  • [42] Bidirectional Modulation of Nociception by GlyT2+ Neurons in the Ventrolateral Periaqueductal Gray
    Assareh, Neda
    Fenech, Caitlin
    Power, Rebecca
    Uddin, Mohammad N.
    Otsu, Yo
    Aubrey, Karin R.
    ENEURO, 2023, 10 (06)
  • [43] Columnar distribution of catecholaminergic neurons in the ventrolateral periaqueductal gray and their relationship to efferent pathways
    Suckow, Shelby K.
    Deichsel, Emily L.
    Ingram, Susan L.
    Morgan, Michael M.
    Aicher, Sue A.
    SYNAPSE, 2013, 67 (02) : 94 - 108
  • [44] Ventrolateral periaqueductal gray neurons prioritize threat probability over fear output
    Wright, Kristina M.
    McDannald, Michael A.
    ELIFE, 2019, 8
  • [45] Medullary catecholaminergic projections to the ventrolateral periaqueductal gray region activated by halothane anaesthesia
    Clement, CI
    Keay, KA
    Bandler, R
    NEUROSCIENCE, 1998, 86 (04) : 1273 - 1284
  • [46] Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray
    Lane, DA
    Tortorici, V
    Morgan, MM
    NEUROSCIENCE, 2004, 125 (01) : 63 - 69
  • [47] Sex differences in projections from preoptic area aromatase cells to the periaqueductal gray in Japanese quail
    Carere, Claudio
    Ball, Gregory F.
    Balthazart, Jacques
    JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 500 (05) : 894 - 907
  • [48] Persistent Inflammation Reduces Cannabinoid 1 Receptor Function in the Ventrolateral Periaqueductal Gray
    Bouchet, Courtney
    Eshleman, Amy
    Janowsky, Aaron
    Ingram, Susan
    FASEB JOURNAL, 2021, 35
  • [49] Differential sensitivity of presynaptic and postsynaptic GABAB receptors in rat ventrolateral periaqueductal gray
    Chen, Qian
    Shao, Caifeng
    Zhou, Hui
    Ma, Rui
    Jiang, Ping
    Yang, Kun
    NEUROREPORT, 2017, 28 (18) : 1221 - 1224
  • [50] Her pain is not his pain, sex differences in migraineurs' periaqueductal gray matter functional connectivity
    Gecse, K.
    Dobos, D.
    Karolyi, N.
    Baksa, D.
    Aranyi, C. S.
    Emri, M.
    Kokonyei, G.
    Bagdy, G.
    Juhasz, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S103 - S104